Sun Pharma was at lifetime high yesterday at Rs 854. It has received final approval for Novartis's Reclast/Aclasta, which is used in the treatment of osteoporosis.
first published: Apr 3, 2013 03:12 pm
A collection of the most-viewed Moneycontrol videos.

Small town, Big tech: Sridhar Vembu on Zoho’s rural push, AI Bubble, SaaS consolidation & many more

Live: DAVOS 2026 Day 5 Highlights: Elon Musk, AI Innovations & India’s Investment Pitch

Budget 2026 Decoded ? Key Terms You Must Know | Inflation, Taxes & Spending

Live: Sensex tumbles 2,000 pts this week, Nifty gives up 25,100 | Closing Bell
You are already a Moneycontrol Pro user.

